~~<i id='406E42A99E'><strike id='406E42A99E'><tt id='406E42A99E'><pre id='406E42A99E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：fashion 2025-09-29 18:16:28 - browse：93731

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Questions and answers about ramping up H5N1 bird flu vaccine

knowledge

Wikipedia

knowledge

explore

focus

knowledge

MikeReddyforSTATSimonMatthewsmadethreetripsthisspringtotheemergencyroomofhislocalhospitalinEastbourn

WSS

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Mitch McConnell episode has important public health takeaway

Trump indictment: Who are the 'co

Cue Health, Covid

The high personal cost of affirmative action for Black doctors

focus

explore

knowledge

How one medical school became remarkably diverse

Amazon expands telehealth clinic nationwide

The high cost of giving birth even with insurance

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Novavax promises a turnaround & Lilly roils the obesity market

Biogen joins immunology wave with $1.15 billion acquisition of HI

Medical leaders decry Supreme Court decision on affirmative action

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Virginia high school admissions case could be legal follow

Bird flu surveillance in wastewater gets boost from consortium

Wikipedia

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Mitch McConnell episode has important public health takeaway

Sage hopes for a blockbuster in antidepressant now before FDA

Physician groups backed by private equity giant lobby on mergers

Fentanyl is making it harder to start addiction treatment

What the US credit downgrade means for the economy, your finances

knowledge

explore

focus

knowledge